Sold out

Management of cancer - Multiple options...

English · Paperback / Softback

Description

Read more

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Some medical scientists have studied and scrutinized the hundreds of molecules which can improve the treatment of bowel cancer through the process of chemotherapy. In fact, the researchers have advanced that the process of blocking a molecular switch which is a molecule that can shift between two or more states called miR-224 tricks bowel cancer cells, can also contain a healthy gene called K-RAS into behaving like cells with a damaged form of the gene. In-depth medical research have demonstrated that the K-RAS has the capacity to control the normal growth of healthy bowel cells. However, there are faulty versions of the gene which are found in one-third of bowel cancers! Did you know that bowel cancer is one of the most common cancers in the United Kingdom? Well, this is an actual fact! Official statistics have shown that there are more than 41,000 cases of bowel cancer which is diagnosed every year. Medical research have also found that there are multiple patients who are treated with a drug called 5-fluorouracil. Unfortunately, medical specialists have also revealed that not all patients respond well to the 5- fluorouracil...

Product details

Assisted by Edward R. Miller-Jones (Editor), Edwar R Miller-Jones (Editor)
Publisher FastBook Publishing
 
Languages English
Product format Paperback / Softback
Released 09.11.2012
 
EAN 9786130144500
ISBN 978-613-0-14450-0
No. of pages 116
Subject Natural sciences, medicine, IT, technology > Medicine

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.